Parimifasor
Parimifasor (LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD) .
Product Specifications
CAS Number
1796641-10-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
460.214
Molecular Formula
C18H11Cl2F4N5O
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ANT-37255-100ug 100 µg
HSV1/HHV1 gD/Envelope glycoprotein D, InVivo Block/Neutralizing Antibody
Ask
View Details 